PMID: 8454912Feb 1, 1993Paper

2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C

Journal of Interferon Research
G GiannelliO Schiraldi

Abstract

The 2',5'-oligoadenylate (2-5A) synthetase is an intracellular enzyme induced by interferon (IFN). We evaluated the serum level of this enzyme in 25 patients affected by chronic hepatitis C and treated with recombinant IFN-alpha 2b. At the end of treatment, 14 patients were classified as responders and 11 as nonresponders. Before therapy initiation no significant differences in 2-5A synthetase levels among the patients were detected, while during therapy responders showed higher mean levels of 2-5A synthetase than nonresponders. An increase in the enzyme activity was observed after 1 month of therapy, and this trend was maintained in the following 2 months. The peak of 2-5A synthetase activity was found at the end of therapy. 2-5A synthetase levels were negatively correlated with serum alanine aminotransferase (ALT). This study suggests that 2-5A synthetase may be a useful marker to monitor IFN efficacy during treatment and to predict the clinical response.

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A SchmidtM Revel
Aug 1, 1992·Journal of Interferon Research·I M Kerr, G R Stark
Jan 1, 1991·Journal of Hepatology·G Hess
Apr 1, 1990·British Medical Bulletin·M R Jacyna, H C Thomas
Mar 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ShindoY Sokawa
Nov 30, 1989·The New England Journal of Medicine·A M Di BisceglieJ H Hoofnagle
Nov 1, 1989·Seminars in Liver Disease·J H Hoofnagle, A M Di Bisceglie
Nov 1, 1989·Seminars in Liver Disease·F Rosina, M Rizzetto
Feb 1, 1980·Virology·A G Hovanessian, J N Wood

❮ Previous
Next ❯

Citations

Jan 1, 1994·Biotherapy·N B Finter
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshiki SuginoshitaTsutomu Chiba
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shengyuan LuoCharles D Howell
Jan 17, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Masami Ogawa, Akiko Morisada
Jan 1, 1997·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·S KanemaruY Tamura
Jan 29, 2013·Expert Opinion on Biological Therapy·Carolina Scagnolari, Guido Antonelli
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J P ZarskiM F Girardin
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E MizukoshiK Kobayashi
Sep 1, 1995·Medicinal Research Reviews·G C ViscomiS Silvestri
Feb 3, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Gianluigi GiannelliSalvatore Antonaci
Dec 6, 2014·Nucleic Acids Research·Virginia K VachonGraeme L Conn
Sep 1, 2004·Clinical Therapeutics·S James Matthews, Christopher McCoy
Oct 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J M PawlotskyD Dhumeaux
Sep 12, 2018·Drug and Chemical Toxicology·Sevcan MamurDeniz Yüzbaşıoğlu
Feb 6, 2020·Viruses·Han DiMargo A Brinton
Jan 11, 2020·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver (KASL)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.